The exploration of stem cell research for the treatment of ALS offers tremendous hope for patients and families affected by the disease, and remains a major focus of the international ALS research community. Dr. Mark Erwin, Principal Investigator from the Krembil Research Institute, has partnered up with the University of Toronto, the University Health Network (UHN), and Sunnybrook Hospital to advance a novel approach to treating ALS which harnesses the power of regenerative medicine.
They are the only ones in the world to be doing this particular kind of work. They have been able to non-surgically transplant stem cells that have been pre-differentiated into motor neurons-directly into the spinal cord. NO SURGERY required and they can target precisely where in the spinal cord they want the cells to go. A delivery method currently approved by the Canadian FDA. The results thus far have been breath taking. This is ground breaking, world leading technology! To Help Fund This Click Here!
Pioneering A World- First treatment for ALS
ALS Fact Sheets (via ALS Society of Canada)
Clinical Trials Q&A (via ALS Society of Canada)
Therapeutic/Stem Cell – Known Open Trials In Canada/USA
Nutritional – Known Open Trials Globally
Traditional Medicine -Investigation of Alternative or off label ALS Treatments Globally
Other – Investigation of Alternative or off label ALS Treatments Globally
ALSA/NEALS PALS Webinar: ALS and the Clinical Trial Process
Tuesday, December 1, 2015 3:00pm – 4:00pm ET
Interested in enrolling in a trial, but need to understand the research process better? Watch this webinar for an introduction to the ALS clinical research process. Dr. James Berry, Co-Director of the Mass General Hospital ALS Multidisciplinary Clinic, reviews clinical trial terminology, online resources, and steps for enrolling in a trial. Click here to watch a recording of this webinar.
ALSA/NEALS PALS Webinar: ALS Clinical Trial Pipeline Series – Fall 2015
Thursday, October 22, 2015 2:30pm – 3:30pm ET
Dr. Angela Genge, Montreal Neurological Institute and Hospital, provides an update on drugs currently in development for Amyotrophic Lateral Sclerosis (ALS). Click here to watch a recording of this webinar.